Research, lived experience, and the responsibility to support injured first responders. What is the value of developing better treatments if support systems for injured first responders cannot make timely decisions about access? This question arose after the Black Dog Institute announced, as reported by ABC Australia on 27 October 2026, a proposed 2027 clinical trial examining ketamine combined with exposure-based therapy for emergency service workers with persistent PTSD. I